chronic fatigue syndrome

GPTKB entity

Statements (71)
Predicate Object
gptkbp:instance_of gptkb:disease
gptkb:computer
gptkbp:advocacy research funding
awareness campaigns
funding for research
patient organizations
gptkbp:affects energy levels
all ages
both genders
gptkbp:associated_with post-exertional malaise
gptkbp:cause gptkb:unknown
gptkbp:condition gptkb:depression
anxiety disorders
fibromyalgia
irritable bowel syndrome
orthostatic intolerance
gptkbp:demographics more common in women
can affect all ages
gptkbp:diagnosis gptkb:Fukuda_criteria
clinical evaluation
Canadian Consensus Criteria
gptkbp:historical_context previously known as 'chronic fatigue immune dysfunction syndrome'
first described in the 1980s
https://www.w3.org/2000/01/rdf-schema#label chronic fatigue syndrome
gptkbp:impact mental health
physical health
quality of life
social interactions
daily activities
work productivity
work capacity
gptkbp:known_as gptkb:Myalgic_Encephalomyelitis
gptkb:multiple_sclerosis
gptkbp:premiered_on often sudden
can follow viral infections
can follow an infection
gptkbp:prevalence affects millions worldwide
estimated 836,000 to 2.5 million Americans
gptkbp:previously_known_as chronic fatigue immune dysfunction syndrome
gptkbp:public_awareness increasing in recent years
gptkbp:research_focus genetic factors
psychological factors
viral infections
immune system
treatment options
biological markers
underlying causes
gptkbp:symptoms muscle pain
sleep disturbances
sore throat
joint pain
cognitive difficulties
headaches
extreme fatigue
persistent fatigue
post-exertional malaise
gptkbp:title gptkb:benign_myalgic_encephalomyelitis
chronic fatigue immune dysfunction syndrome
neurasthenia
post-viral fatigue syndrome
gptkbp:treatment gptkb:pharmaceuticals
cognitive behavioral therapy
nutritional supplements
lifestyle changes
symptomatic management
graded exercise therapy
alternative therapies
sleep aids
medications for pain relief
gptkbp:bfsParent gptkb:Liza_Minnelli
gptkbp:bfsLayer 3